Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Fourth Quarter Earnings
April 01 2010 - 11:18AM
Business Wire
Forest Laboratories, Inc. (NYSE: FRX), an international
manufacturer and marketer of pharmaceutical products, will release
its Fiscal 2010 Fourth Quarter financial results before the U.S.
stock market opens on Tuesday, April 20, 2010. At 10:00 AM EDT,
Forest will host a conference call where Dr. Lawrence Olanoff,
President and Chief Operating Officer and Frank Perier, Senior Vice
President-Finance and Chief Financial Officer, will discuss the
financial results and relevant company and industry topics. The
conference call will be webcast live beginning at 10:00 AM EDT on
the Company's website www.frx.com and also on the website
www.streetevents.com. Please log on to either website at least
fifteen minutes prior to the conference call as it may be necessary
to download software to access the call. A replay of the conference
call will be available until May 4, 2010 at both websites and also
by dialing 1-800-642-1687 (US investors) or +1-706-645-9291
(international investors), Conference Call ID 66177364.
About Forest
Laboratories
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical
company with a long track record of building partnerships and
developing and marketing products that make a positive difference
in people’s lives. In addition to its well-established franchises
in therapeutic areas of the central nervous and cardiovascular
systems, Forest’s current pipeline includes product candidates in
all stages of development and across a wide range of therapeutic
areas. The Company is headquartered in New York, NY. To learn more
about Forest Laboratories, visit www.frx.com.
Except for the historical information contained herein, this
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
statements involve a number of risks and uncertainties, including
the difficulty of predicting FDA approvals, the acceptance and
demand for new pharmaceutical products, the impact of competitive
products and pricing, the timely development and launch of new
products, and the risk factors listed from time to time in Forest
Laboratories’ Annual Report on Form 10-K, Quarterly Report on Form
10-Q, and any subsequent SEC filings.
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024